Literature DB >> 22354970

p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.

Annika Müer1, Tim Overkamp, Bernd Gillissen, Antje Richter, Thomas Pretzsch, Ana Milojkovic, Bernd Dörken, Peter T Daniel, Philipp Hemmati.   

Abstract

The p14(ARF) tumor suppressor plays a central role in regulating cell cycle arrest and apoptosis. We reported previously that p14(ARF) is capable of triggering apoptosis in a p53-independent manner. However, the mechanism remained unclear. Here we demonstrate that the p53-independent activation of the mitochondrial apoptosis pathway by p14(ARF) is primarily mediated by the pro-apoptotic Bax-homolog Bak. Expression of p14(ARF) exclusively triggers a N-terminal conformational switch of Bak, but not Bax, which allows for mitochondrial permeability shift, release of cytochrome c, activation of caspases, and subsequent fragmentation of genomic DNA. Although forced expression of Bak markedly sensitizes toward p14(ARF)-induced apoptosis, re-expression of Bax has no effect. Vice versa, knockdown of Bak by RNA interference attenuates p14(ARF)-induced apoptosis, whereas down-regulation of Bax has no effect. Bak activation coincides with a prominent, caspase-independent deprivation of the endogenous Bak inhibitors Mcl-1 and Bcl-x(L). In turn, mitochondrial apoptosis is fully blocked by overexpression of either Mcl-1 or Bcl-x(L). Taken together, these data indicate that in the absence of functional p53 and Bax, p14(ARF) triggers mitochondrial apoptosis signaling by activating Bak, which is facilitated by down-regulating anti-apoptotic Mcl-1 and Bcl-x(L). Moreover, our data suggest that the simultaneous inhibition of two central endogenous Bak inhibitors, i.e. Mcl-1 and Bcl-x(L), may be sufficient to activate mitochondrial apoptosis in the absence of BH3-only protein regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354970      PMCID: PMC3366797          DOI: 10.1074/jbc.M111.314898

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Induction of the human ARF protein by serum starvation.

Authors:  R Inoue; C Asker; U Klangby; P Pisa; K G Wiman
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

2.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

3.  ARF induces autophagy by virtue of interaction with Bcl-xl.

Authors:  Julia Pimkina; Olivier Humbey; Jack T Zilfou; Michal Jarnik; Maureen E Murphy
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

Review 4.  Control of mitochondrial apoptosis by the Bcl-2 family.

Authors:  Joslyn K Brunelle; Anthony Letai
Journal:  J Cell Sci       Date:  2009-02-15       Impact factor: 5.285

5.  Human ARF binds E2F1 and inhibits its transcriptional activity.

Authors:  B Eymin; L Karayan; P Séité; C Brambilla; E Brambilla; C J Larsen; S Gazzéri
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

Review 6.  Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

Authors:  S J Korsmeyer; M C Wei; M Saito; S Weiler; K J Oh; P H Schlesinger
Journal:  Cell Death Differ       Date:  2000-12       Impact factor: 15.828

7.  Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

Authors:  Heidi LeBlanc; David Lawrence; Eugene Varfolomeev; Klara Totpal; John Morlan; Peter Schow; Sharon Fong; Ralph Schwall; Dominick Sinicropi; Avi Ashkenazi
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

8.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

Authors:  T Lindsten; A J Ross; A King; W X Zong; J C Rathmell; H A Shiels; E Ulrich; K G Waymire; P Mahar; K Frauwirth; Y Chen; M Wei; V M Eng; D M Adelman; M C Simon; A Ma; J A Golden; G Evan; S J Korsmeyer; G R MacGregor; C B Thompson
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

9.  Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis.

Authors:  A Nechushtan; C L Smith; I Lamensdorf; S H Yoon; R J Youle
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

10.  Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members.

Authors:  Tristan Gallenne; Fabien Gautier; Lisa Oliver; Eric Hervouet; Belinda Noël; John A Hickman; Olivier Geneste; Pierre-François Cartron; François M Vallette; Stephen Manon; Philippe Juin
Journal:  J Cell Biol       Date:  2009-04-20       Impact factor: 10.539

View more
  13 in total

1.  To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation?

Authors:  Antonella Ronchi; Sergio Ottolenghi
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

Review 2.  Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!

Authors:  Ruju Vashi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

3.  Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.

Authors:  Cindrilla Chumduri; Bernhard Gillissen; Anja Richter; Antje Richter; Ana Milojkovic; Tim Overkamp; Anja Müller; Christiane Pott; Peter T Daniel
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

4.  Exercise effects on DNA methylation in EVL, CDKN2A (p14, ARF), and ESR1 in colon tissue from healthy men and women.

Authors:  Catherine Duggan; Ming Yu; Amber R Willbanks; Jean de Dieu Tapsoba; Ching-Yun Wang; William M Grady; Anne McTiernan
Journal:  Epigenetics       Date:  2021-10-06       Impact factor: 4.861

5.  Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype.

Authors:  Benjamin Gottschalk; Andreas Klein
Journal:  Mol Cell Biochem       Date:  2013-04-07       Impact factor: 3.396

6.  Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins.

Authors:  Katharine J Goodall; Megan L Finch-Edmondson; Joanne van Vuuren; George C Yeoh; Ian E Gentle; James E Vince; Paul G Ekert; David L Vaux; Bernard A Callus
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

7.  Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis.

Authors:  Fang Wang; Heping Li; Jianting Long; Sheng Ye
Journal:  Onco Targets Ther       Date:  2017-05-08       Impact factor: 4.147

8.  Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells.

Authors:  Long Cui; Bo Liang; Yihua Yang; Minhui Zhu; Joseph Kwong; Hongliang Zheng; Chi Chiu Wang
Journal:  Oncotarget       Date:  2017-09-28

9.  Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.

Authors:  Sumaira Amir; Ai-Hong Ma; Xu-Bao Shi; Lingru Xue; Hsing-Jien Kung; Ralph W Devere White
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  p53 and Ceramide as Collaborators in the Stress Response.

Authors:  Rouba Hage-Sleiman; Maria O Esmerian; Hadile Kobeissy; Ghassan Dbaibo
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.